Cara Therapeutics Inc CARA:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 04/30/24 EDT
0.7519quote price arrow down-0.0036 (-0.4765%)
Volume
187,080
52 week range
0.50 - 4.67
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.7519
  • 52 Week High4.67
  • 52 Week High Date05/16/23
  • 52 Week Low0.50
  • 52 Week Low Date01/25/24

Key Stats

  • Market Cap41.104M
  • Shares Out54.67M
  • 10 Day Average Volume0.32M
  • Dividend-
  • Dividend Yield-
  • Beta0.73
  • YTD % Change1.2

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.7519
  • 52 Week High4.67
  • 52 Week High Date05/16/23
  • 52 Week Low0.50
  • 52 Week Low Date01/25/24
  • Market Cap41.104M
  • Shares Out54.67M
  • 10 Day Average Volume0.32M
  • Dividend-
  • Dividend Yield-
  • Beta0.73
  • YTD % Change1.2

RATIOS/PROFITABILITY

  • EPS (TTM)-2.19
  • P/E (TTM)-0.34
  • Fwd P/E (NTM)-0.68
  • EBITDA (TTM)-121.236M
  • ROE (TTM)-109.80%
  • Revenue (TTM)20.968M
  • Gross Margin (TTM)70.56%
  • Net Margin (TTM)-565.21%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/13/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Cara Therapeutics Inc

 

Profile

MORE
Cara Therapeutics, Inc. is a development-stage biopharmaceutical company. The Company is focused on treatment paradigm to improve the lives of patients suffering from chronic pruritus. It is developing an oral formulation of difelikefalin, a selective, predominantly peripherally acting, non-scheduled Kappa opioid receptor agonist, for the treatment of chronic neuropathic pruritus associated with Notalgia Paresthetica (NP), a common, underdiagnosed neuropathy affecting the...
Martin Vogelbaum
Independent Chairman of the Board
Christopher Posner
President, Chief Executive Officer, Director
Ryan Maynard
Chief Financial Officer
Address
400 Atlantic Street, Suite 500
Stamford, CT
06901
United States

Top Peers

SYMBOLLASTCHG%CHG
RPID
Rapid Micro Biosystems Inc
0.984+0.0201+2.0853%
OCUP
Ocuphire Pharma Inc
1.58-0.06-3.94%
AADI
Aadi Bioscience Inc
1.92+0.06+3.23%
ERNA
Eterna Therapeutics Inc
1.77-0.06-3.28%
ALGS
Aligos Therapeutics Inc
0.765+0.0312+4.2518%